CWG
TXG icon

Cornerstone Wealth Group’s 10x Genomics TXG Stock Holding History

Cornerstone Wealth Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$566K Sell
14,753
-1,424
-9% -$37.3K 0.03% 228
2026
Q1 		$372K Buy
16,177
+2,481
+18% +$49.6K 0.02% 280
2025
Q4 		$223K Buy
+13,696
New +$207K 0.02% 351

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cornerstone Wealth Group's TXG Position: Q2 2026 in Review

Cornerstone Wealth Group reduced its 10x Genomics (TXG) stake by 8.8% in Q2 2026, selling an estimated $37.3K and leaving 14,753 shares worth $566K. The position accounts for 0.03% of the portfolio, ranked #228.

Cornerstone Wealth Group first reported a position in TXG in Q4 2025 and has held it in 3 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Cornerstone Wealth Group held 14,753 shares of 10x Genomics worth $566K as of Q2 2026.
  • Cornerstone Wealth Group sold 1,424 10x Genomics shares in Q2 2026, an estimated $37.3K.
  • 10x Genomics made up 0.03% of Cornerstone Wealth Group's portfolio in Q2 2026, its #228 holding.
  • Cornerstone Wealth Group first reported a position in 10x Genomics in Q4 2025 and has held it in 3 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Cornerstone Wealth Group's 13F filing for Q2 2026, filed 27 Jul 2026.